Leicester

Leicester ECMC aims to develop novel therapeutic strategies to treat cancer, particularly with haematological malignancies. A cornerstone of the Centre’s research is to discover and develop novel phytochemicals as potential cancer chemopreventive agents and/or as potential adjuncts to chemotherapy. Biomarkers studies conducted aim to inform treatment decisions and monitor the effectiveness therapies.
Research Areas
Focus
Chemoprevention, haematology, cell signalling, biomarkers, Radiotherapy/Radiobiology
Disease Area
Breast, cervix, colon, rectal, leukaemia, lung, myeloma, non-Hodgkin's lymphoma, prostate, bladder, hepatobiliary (including pancreas)
Goals
Skills

Leicester ECMC principal investigators and staff have a range of skills and expertise.
Facilities

Leicester ECMC has access to a range of research facilities that are utilised in studies.
Achievements

To learn more about the scientific and operational achievements of Leicester ECMC go to:
Centre Lead
Professor W P Steward
Head, Cancer Studies and Molecular Medicine
c/o Mrs Jenny McNair (PA to Professor Steward)
Experimental Cancer Medicine Centre
Cancer Studies and Molecular Medicine
Robert Kilpatrick Clinical Sciences Building
Leicester Royal Infirmary
PO Box 65
Leicester LE2 7LX
Tel: +44 (0) 116 258 7597
Fax: +44 (0) 116 258 7599
Other key personnel
Departmental Manager
Mr Jim Strupish
Cancer Studies and Molecular Medicine
Robert Kilpatrick Clinical Sciences Building
Leicester Royal Infirmary
PO Box 65
Leicester
LE2 7LX
Tel: +44 (0) 116 252 3238
Clinical Trials Enquiries
You can also find out about trials recruiting in Leicester on the CancerHelp UK clinical trials database.
